ImmunoGen, Inc.
(NASDAQ:IMGN)
$31.23
0.01 (0.02%)
Open: 1:51 PM
ImmunoGen Stock Price Graph
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- YTD
- All
ImmunoGen Stock Price Today
ImmunoGen, Inc. (IMGN) stock declined over N/A intraday to trade at $31.235 a share on NASDAQ. The stock opened with a loss of N/A at $31.24 and touched an intraday high of $31.25, falling N/A against the last close of $N/A. The ImmunoGen, Inc. in stock market went to a low of $31.22 during the session.
ImmunoGen Stock Snapshot
$N/A
Prev. Close
N/A
Market Cap
$31.22
Day Low
$31.24
Open
N/A
Number of Shares
$31.25
Day High
N/A
P/E ratio
N/A
EPS (TTM)
2.27
Cash Flow per Share
N/A
Free Float in %
2.06
Book Value
Volume
ImmunoGen Stock Price History Chart
| Date | Open | High | Low | Close | Volume |
|---|
Contact Details
Company Information
EmployeesN/A
BetaN/A
Sales or Revenue$287.61 Million
5Y Sales ChangeN/A
Fiscal Year EndsDec. 2022
SectorHealthcare
IndustryBiotechnology
About Company
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sunirine, a CD123-targeting ADC that is in Phase II clinical trial for treating acute myeloid leukemia and blastic plasmacytoid dendritic cell neoplasm. Its preclinical programs include IMGC936, an ADC in co-development with MacroGenics, Inc.; and IMGN151, an anti FRa product candidate. The company has collaborations with Roche; Amgen/Oxford BioTherapeutics; Bayer HealthCare AG; Eli Lilly and Company; Novartis Institutes for BioMedical Research, Inc.; CytomX Therapeutics, Inc.; Fusion Pharmaceuticals Inc.; Debiopharm International SA; and MacroGenics, Inc. ImmunoGen, Inc. was founded in 1980 and is headquartered in Waltham, Massachusetts.
Peers
Frequently Asked Questions
What is the current ImmunoGen, Inc. (IMGN) stock price?
ImmunoGen, Inc. (NASDAQ: IMGN) stock price is $31.23 in the last trading session. During the trading session, IMGN stock reached the peak price of $31.25 while $31.22 was the lowest point it dropped to. The percentage change in IMGN stock occurred in the recent session was N/A while the dollar amount for the price change in IMGN stock was N/A.
IMGN's industry and sector of operation?
The NASDAQ listed IMGN is part of Biotechnology industry that operates in the broader Healthcare sector. ImmunoGen, Inc. , a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer.
Who are the executives of IMGN?
Ms. Lauren A. White M.B.A.
Senior Vice President & Chief Financial Officer
Mr. Daniel S. Char J.D.
Senior Vice President & Chief Legal Officer
Ms. Audrey Bergan
Senior Vice President & Chief HR Officer
Mr. Joseph J. Kenny
Vice President, Acting Gen. Counsel, Intellectual Property & Sec.
How IMGN did perform over past 52-week?
IMGN's closing price is 3.28% higher than its 52-week low of $3.61 where as its distance from 52-week high of $31.25 is -0.03%.
How many employees does IMGN have?
Number of IMGN employees currently stands at N/A. IMGN operates from 830 Winter Street, Waltham, MA 02451-1477, US.
Link for IMGN official website?
Official Website of IMGN is: https://www.immunogen.com
How do I contact IMGN?
IMGN could be contacted at phone #781 895 0600 and can also be accessed through its website. IMGN operates from 830 Winter Street, Waltham, MA 02451-1477, US.
How many shares of IMGN are traded daily?
IMGN stock volume for the day was 19311442.00 shares. The average number of IMGN shares traded daily for last 3 months was N/A.
What is the market cap of IMGN currently?
The market value of IMGN currently stands at N/A with its latest stock price at $31.23 and N/A of its shares outstanding.